Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rickets | 1 | 2022 | 2 | 0.900 |
Why?
|
| Fanconi Syndrome | 1 | 2022 | 7 | 0.900 |
Why?
|
| Intubation, Intratracheal | 3 | 2015 | 129 | 0.660 |
Why?
|
| Anesthesia, General | 3 | 2019 | 96 | 0.570 |
Why?
|
| Anesthetics | 2 | 2019 | 36 | 0.480 |
Why?
|
| Langer-Giedion Syndrome | 1 | 2013 | 1 | 0.480 |
Why?
|
| Airway Management | 1 | 2013 | 22 | 0.470 |
Why?
|
| Glottis | 1 | 2013 | 32 | 0.460 |
Why?
|
| Postoperative Complications | 4 | 2022 | 1035 | 0.420 |
Why?
|
| Agammaglobulinemia | 1 | 2023 | 10 | 0.230 |
Why?
|
| Tetanus | 1 | 2023 | 8 | 0.230 |
Why?
|
| Nephrotic Syndrome | 1 | 2023 | 21 | 0.230 |
Why?
|
| Homozygote | 1 | 2022 | 60 | 0.220 |
Why?
|
| Lupus Nephritis | 1 | 2022 | 19 | 0.220 |
Why?
|
| Arteriovenous Malformations | 1 | 2013 | 66 | 0.220 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 138 | 0.200 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 127 | 0.190 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 133 | 0.180 |
Why?
|
| Phenotype | 1 | 2022 | 819 | 0.170 |
Why?
|
| Heart Failure, Systolic | 1 | 2018 | 7 | 0.160 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 309 | 0.160 |
Why?
|
| Anesthesia, Epidural | 1 | 2017 | 22 | 0.150 |
Why?
|
| Catheterization | 1 | 2017 | 108 | 0.140 |
Why?
|
| Perioperative Period | 1 | 2016 | 25 | 0.140 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 160 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 146 | 0.140 |
Why?
|
| Liver Transplantation | 1 | 2018 | 159 | 0.140 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2015 | 9 | 0.130 |
Why?
|
| Humans | 11 | 2023 | 54391 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 104 | 0.120 |
Why?
|
| Face | 1 | 2013 | 66 | 0.110 |
Why?
|
| Cochlear Implantation | 1 | 2013 | 71 | 0.110 |
Why?
|
| Child | 4 | 2022 | 7368 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 404 | 0.100 |
Why?
|
| Kidney | 1 | 2016 | 822 | 0.090 |
Why?
|
| Consciousness Monitors | 1 | 2019 | 5 | 0.090 |
Why?
|
| Arterial Pressure | 1 | 2019 | 50 | 0.090 |
Why?
|
| Postoperative Period | 1 | 2019 | 189 | 0.090 |
Why?
|
| Female | 6 | 2019 | 28471 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2022 | 6459 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1229 | 0.070 |
Why?
|
| Lip | 1 | 2013 | 11 | 0.060 |
Why?
|
| Tongue | 1 | 2013 | 41 | 0.060 |
Why?
|
| Mouth | 1 | 2013 | 35 | 0.060 |
Why?
|
| Sclerotherapy | 1 | 2013 | 47 | 0.060 |
Why?
|
| Ifosfamide | 1 | 2022 | 9 | 0.060 |
Why?
|
| Steroids | 1 | 2023 | 55 | 0.060 |
Why?
|
| Developing Countries | 1 | 2022 | 51 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 248 | 0.050 |
Why?
|
| Recurrence | 1 | 2023 | 692 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2022 | 193 | 0.050 |
Why?
|
| Aged | 2 | 2019 | 10060 | 0.050 |
Why?
|
| Male | 4 | 2019 | 27347 | 0.050 |
Why?
|
| Risk Factors | 2 | 2022 | 3937 | 0.050 |
Why?
|
| Ohio | 1 | 2018 | 67 | 0.040 |
Why?
|
| Epidural Space | 1 | 2017 | 10 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2018 | 151 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2017 | 38 | 0.040 |
Why?
|
| Warm Ischemia | 1 | 2016 | 4 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 59 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2017 | 248 | 0.030 |
Why?
|
| Laryngeal Masks | 1 | 2015 | 9 | 0.030 |
Why?
|
| Creatinine | 1 | 2016 | 169 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 139 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2016 | 93 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 954 | 0.030 |
Why?
|
| Echocardiography | 1 | 2018 | 392 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2015 | 121 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1083 | 0.030 |
Why?
|
| Adult | 2 | 2022 | 14207 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 2126 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2390 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1082 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2023 | 5612 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 2606 | 0.020 |
Why?
|
| Middle Aged | 2 | 2017 | 13082 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 565 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 3210 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2015 | 2923 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 3829 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 4158 | 0.020 |
Why?
|